Epidemiology and clinical presentation of kidney amyloidosis have changed over the past three decades: a nationwide population-based study
The epidemiology of kidney amyloidosis has changed over the past 30 years. Biopsy incidence of non-AA is increased, and findings may suggest an earlier diagnosis. Amyloid typing has improved over time and is reflected in more precise amyloid diagnoses and reduced number of undetermined cases in recent years. Although AA related to rheumatic disease is declining, AA amyloidosis in people who inject drugs represents a growing challenge. The changing epidemiology of kidney amyloidosis may impact clinical presentation and future healthcare needs, emphasising the need for amyloid awareness.
Authors
- Anna Varberg Reisæter (ORCID: https://orcid.org/0000-0003-3195-5558)
- Anders Åsberg (ORCID: https://orcid.org/0000-0002-0628-1769)
- Arnljot Tveit (ORCID: https://orcid.org/0000-0002-7223-5138)
- Rannveig Skrunes
- Melinda Ráki
- Helga Gudmundsdottir
- Sabine Leh (ORCID: https://orcid.org/0000-0002-0764-2941)
- Anders Hartmann (ORCID: https://orcid.org/0000-0002-4135-2673)
- J Thomsen
- Tale Norbye Wien (ORCID: https://orcid.org/0000-0001-8883-2642)
- Hilde J Vasstrand
Institutions
- Oslo University Hospital (NO)
- University of Oslo (NO)
- Vestre Viken Hospital Trust (NO)
- Haukeland University Hospital (NO)
- University of Bergen (NO)
Publication Details
- Journal
- BMC Nephrology
- Published
- 2025-06-02
- DOI
- https://doi.org/10.1186/s12882-025-04136-w
- Citations
- 2
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.61
Funders
- Helse Sør-Øst RHF